Coronary Access After Supra-Annular THV Implantation

Status unconfirmed · Not applicable

Conditions studied: Coronary Angiography, Transcatheter Aortic Valve Replacement

In brief

To determine the optimal technique and equipment for selective coronary engagement specifically following Evolut THV implantation using commissural alignment.

Key facts

Study ID

NCT05075590

Run by

University of British Columbia

People needed

50

Starts

2021-10-27

Expected to finish

2024-07-31

Last updated by the study team

2023-12-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing elective transfemoral TAVR with the Evolut THV (Medtronic, Minneapolis, MN, USA).
• Written informed consent to participate in the study.

You may not qualify if…

• Hemodynamic or respiratory instability immediately prior to TAVR or during TAVR.
• Advanced chronic kidney disease, defined as a GFR <30 ml/min.
• Valve-in-valve TAVR
• Prior CABG
• Aorto-ostial coronary artery disease.
• Prior PCI of the left main or right coronary ostium

Where it is running

• Vancouver General Hospital — Vancouver, British Columbia, Canada (enrolling)
• St. Paul's Hospital — Vancouver, British Columbia, Canada (enrolling)
• UPMC Harrisburg — Harrisburg, Pennsylvania, United States
• Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.